Temat: "COVID-19" - Prolib Integro

Skocz do pozycji: 1 1.

Tytuł :: What the SARS-CoV-2 Pandemic Has Taught Us About Immunosuppression, Vaccinations, and Immune Dysregulation: The Rheumatology Experience.
Autorzy :: Jiang Y; Division of Pediatric Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Sadun RE; Division of Pediatric Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA. .; Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. .; Pokaż więcej
Źródło :: Current allergy and asthma reports [Curr Allergy Asthma Rep] 2024 Apr; Vol. 24 (4), pp. 221-232. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji :: Journal Article; Review
MeSH Terms :: COVID-19*/*complications
COVID-19*/epidemiology
COVID-19*/prevention & control
Rheumatology*
Systemic Inflammatory Response Syndrome*
Child ; Humans ; United States ; SARS-CoV-2 ; Pandemics/prevention & control ; COVID-19 Vaccines/therapeutic use ; Post-Acute COVID-19 Syndrome ; Immunosuppression Therapy ; Vaccination
SCR Disease Name :: pediatric multisystem inflammatory disease, COVID-19 related
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: A prospective observational cohort study of covid-19 epidemiology and vaccine seroconversion in South Western Sydney, Australia, during the 2021-2022 pandemic period.
Autorzy :: Potter D; University of Western Sydney, Sydney, NSW, Australia. .; University of New South Wales, Sydney, NSW, Australia. .; Department of Renal Medicine, Liverpool Hospital, Liverpool, Sydney, NSW, Australia. .
Diep J; Department of Renal Medicine, Liverpool Hospital, Liverpool, Sydney, NSW, Australia.
Munro C; Department of Renal Medicine, Liverpool Hospital, Liverpool, Sydney, NSW, Australia.
Lin N; Department of Renal Medicine, Liverpool Hospital, Liverpool, Sydney, NSW, Australia.
Xu R; Department of Renal Medicine, Liverpool Hospital, Liverpool, Sydney, NSW, Australia.
Wong J; Department of Renal Medicine, Liverpool Hospital, Liverpool, Sydney, NSW, Australia.
Porritt R; Department of Microbiology and Infectious Diseases, NSW Health Pathology, Liverpool, NSW, Australia.
Maley M; Department of Microbiology and Infectious Diseases, NSW Health Pathology, Liverpool, NSW, Australia.
Foo H; Department of Microbiology and Infectious Diseases, NSW Health Pathology, Liverpool, NSW, Australia.
Makris A; University of Western Sydney, Sydney, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia.; Department of Renal Medicine, Liverpool Hospital, Liverpool, Sydney, NSW, Australia.; Pokaż więcej
Źródło :: BMC nephrology [BMC Nephrol] 2024 Apr 12; Vol. 25 (1), pp. 131. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji :: Observational Study; Journal Article
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Humans ; Male ; Middle Aged ; Female ; Prospective Studies ; Australia/epidemiology ; COVID-19 Testing ; COVID-19 Vaccines ; Pandemics ; Seroconversion ; Renal Dialysis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Symptomology following COVID-19 among adults in Alberta, Canada: an observational survey study.
Autorzy :: Chen X; Alberta Strategy for Patient-Oriented Research Support Unit Data Platform, Edmonton, Alberta, Canada.; Provincial Research Data Services, Alberta Health Services, Edmonton, Alberta, Canada.
Norris C; Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.
Whitten T; Alberta Strategy for Patient-Oriented Research Support Unit Data Platform, Edmonton, Alberta, Canada.; Provincial Research Data Services, Alberta Health Services, Edmonton, Alberta, Canada.
Ho C; Alberta Health Services, Edmonton, Alberta, Canada.; University of Alberta, Edmonton, Alberta, Canada.
Mann B; Alberta Health Services, Edmonton, Alberta, Canada.
Bakal J; Alberta Strategy for Patient-Oriented Research Support Unit Data Platform, Edmonton, Alberta, Canada .; Provincial Research Data Services, Alberta Health Services, Edmonton, Alberta, Canada.; Alberta Health Services, Edmonton, Alberta, Canada.; Pokaż więcej
Źródło :: BMJ open [BMJ Open] 2024 Mar 08; Vol. 14 (3), pp. e078119. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji :: Observational Study; Journal Article
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/complications
Adult ; Middle Aged ; Humans ; Female ; SARS-CoV-2 ; Alberta/epidemiology ; Post-Acute COVID-19 Syndrome ; COVID-19 Testing ; Pandemics ; Headache/etiology ; Headache/complications ; Self Report ; Fatigue/epidemiology ; Fatigue/etiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020-2022.
Autorzy :: MacCallum-Bridges C; University of Michigan Department of Epidemiology, 1415 Washington Heights, Ann Arbor, MI 48109, United States. Electronic address: .
Hirschtick JL; University of Michigan Department of Epidemiology, 1415 Washington Heights, Ann Arbor, MI 48109, United States.
Patel A; University of Michigan Department of Epidemiology, 1415 Washington Heights, Ann Arbor, MI 48109, United States.
Orellana RC; CDC Foundation., 600 Peachtree Street NE #1000, Atlanta, GA 30308, United States; Michigan Department of Health and Human Services, 333 South Grand Avenue, Lansing, MI 48933, United States.
Elliott MR; University of Michigan Department of Biostatistics, 1415 Washington Heights, Ann Arbor, MI 48109, United States; University of Michigan Survey Research Center, 426 Thompson Street, Ann Arbor, MI 48104, United States.
Fleischer NL; University of Michigan Department of Epidemiology, 1415 Washington Heights, Ann Arbor, MI 48109, United States.; Pokaż więcej
Źródło :: Annals of epidemiology [Ann Epidemiol] 2024 Apr; Vol. 92, pp. 17-24. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji :: Journal Article
MeSH Terms :: Post-Acute COVID-19 Syndrome*
COVID-19*/epidemiology
COVID-19*/prevention & control
Adult ; Humans ; COVID-19 Vaccines/therapeutic use ; Prevalence ; Sampling Studies ; SARS-CoV-2 ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Long COVID in pediatrics-epidemiology, diagnosis, and management.
Autorzy :: Toepfner N; Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. .
Brinkmann F; Division of Pediatric Pulmonology and Allergology, University Children's Hospital, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Luebeck, Germany.
Augustin S; MRI Chronic Fatigue Center for Young People, Pediatrics, Children's Hospital, Technical University Munich and Munich Municipal Hospital, Munich, Germany.
Stojanov S; MRI Chronic Fatigue Center for Young People, Child and Adolescent Psychosomatics, Children's Hospital, Technical University Munich and Munich Municipal Hospital, Munich, Germany.
Behrends U; MRI Chronic Fatigue Center for Young People, Pediatrics, Children's Hospital, Technical University Munich and Munich Municipal Hospital, Munich, Germany.; Pokaż więcej
Źródło :: European journal of pediatrics [Eur J Pediatr] 2024 Apr; Vol. 183 (4), pp. 1543-1553. Date of Electronic Publication: 2024 Jan 27.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Fatigue Syndrome, Chronic*
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/therapy
Adolescent ; Humans ; Child ; Infant, Newborn ; Post-Acute COVID-19 Syndrome ; Quality of Life ; SARS-CoV-2 ; Disease Progression ; COVID-19 Testing
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
Autorzy :: Zedan HT; Infectious Diseases Department, Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
Smatti MK; Infectious Diseases Department, Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.
Al-Sadeq DW; College of Medicine, Member of QU Health, Qatar University, Doha, Qatar.
Al Khatib HA; Infectious Diseases Department, Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.
Nicolai E; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Pieri M; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Bernardini S; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Hssain AA; Medical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar.
Taleb S; Department of Research, Weill Cornell Medicine-Qatar, Doha, Qatar.
Qotba H; Department of Clinical Research, Primary Health Care Centers, Doha, Qatar.; Department of Pathology, Sidra Medicine, Doha, Qatar.
Issa K; Proteomics, Inflammatory Response, and Mass Spectrometry (PRISM) Laboratory, INSERM U-1192, University of Lille, Lille, France.
Abu Raddad LJ; Department of Population Health Sciences, Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Doha, Qatar.
Althani AA; Infectious Diseases Department, Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
Nasrallah GK; Infectious Diseases Department, Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
Yassine HM; Infectious Diseases Department, Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.; Pokaż więcej
Źródło :: Journal of medical virology [J Med Virol] 2024 Mar; Vol. 96 (3), pp. e29527.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19 Vaccines*
COVID-19*/prevention & control
Humans ; BNT162 Vaccine ; SARS-CoV-2 ; COVID-19 Serotherapy ; Antibodies, Neutralizing ; Antibody-Dependent Cell Cytotoxicity ; Antibodies, Viral ; Vaccination
SCR Organism :: SARS-CoV-2 variants
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Retinal Artery and Vein Occlusion Risks after Coronavirus Disease 2019 or Coronavirus Disease 2019 Vaccination.
Autorzy :: Park HS; Department of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan, South Korea; Department of Ophthalmology, Soonchunhyang University Hospital Bucheon, Bucheon, South Korea.
Lee NK; Department of Computer Science and Engineering, Sungkyunkwan University, Suwon, South Korea.
Lee CS; The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea.
Byeon SH; The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea.
Kim SS; The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea.
Lee SW; Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, South Korea. Electronic address: .
Kim YJ; The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: .; Pokaż więcej
Źródło :: Ophthalmology [Ophthalmology] 2024 Mar; Vol. 131 (3), pp. 322-332. Date of Electronic Publication: 2023 Sep 20.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19*/complications
COVID-19 Vaccines*/adverse effects
Retinal Artery Occlusion*/etiology
Retinal Artery Occlusion*/complications
Retinal Vein Occlusion*/epidemiology
Retinal Vein Occlusion*/etiology
Retinal Vein Occlusion*/diagnosis
Female ; Humans ; Male ; 2019-nCoV Vaccine mRNA-1273 ; Cohort Studies ; COVID-19 Testing ; Retinal Artery ; Vaccination/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Evaluating a peer-to-peer health education program in Australian public housing communities during the COVID-19 pandemic.
Autorzy :: Oliver J; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC, 3000, Australia. .; Murdoch Children's Research Institute, Melbourne, VIC, 3052, Australia. .
Ferdinand A; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, 3000, Australia.
Hussein A; North Melbourne Resident Action Group, Melbourne, VIC, 3052, Australia.
Hussein R; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC, 3000, Australia.
Kaufman J; Murdoch Children's Research Institute, Melbourne, VIC, 3052, Australia.
Edler P; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC, 3000, Australia.
Allard N; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC, 3000, Australia.; cohealth, Melbourne, VIC, 3066, Australia.
Danchin M; Murdoch Children's Research Institute, Melbourne, VIC, 3052, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3000, Australia.; Department of General Medicine, The Royal Childrens Hospital Melbourne, Melbourne, VIC, 3052, Australia.
Gibney KB; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC, 3000, Australia.; Pokaż więcej
Źródło :: BMC health services research [BMC Health Serv Res] 2024 Feb 27; Vol. 24 (1), pp. 250. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Pandemics/prevention & control ; COVID-19 Vaccines ; COVID-19 Testing ; Public Housing ; Australia/epidemiology ; Health Education
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: The lingering symptoms of post-COVID-19 condition (long-COVID): a prospective cohort study.
Autorzy :: Tan S; Physician in Trauma and Rehabilitation Medicine, Illawarra Shoalhaven Local Health District, New South Wales, Australia.; Senior Staff Specialist, Wollongong Hospital, Wollongong, New South Wales, Australia.; Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
Pryor AJG; Research Central, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.
Melville GW; Research Central, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.; Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia.
Fischer O; Research Central, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.
Hewitt L; Research Central, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.; Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia.
Davis KJ; Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.; Research Central, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.; Pokaż więcej
Źródło :: Internal medicine journal [Intern Med J] 2024 Feb; Vol. 54 (2), pp. 224-233. Date of Electronic Publication: 2023 Nov 26.
Typ publikacji :: Observational Study; Journal Article
MeSH Terms :: Chronic Pain*
COVID-19*/epidemiology
Female ; Humans ; Chronic Disease ; COVID-19 Testing ; Fatigue/epidemiology ; Post-Acute COVID-19 Syndrome ; Prospective Studies ; Male
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.
Autorzy :: Woldegiorgis M; Communicable Disease Control Directorate, Western Australia Department of Health, Perth, WA.; National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.
Cadby G; Communicable Disease Control Directorate, Western Australia Department of Health, Perth, WA.
Ngeh S; Communicable Disease Control Directorate, Western Australia Department of Health, Perth, WA.
Korda RJ; National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.
Armstrong PK; Communicable Disease Control Directorate, Western Australia Department of Health, Perth, WA.
Maticevic J; Communicable Disease Control Directorate, Western Australia Department of Health, Perth, WA.
Knight P; Communicable Disease Control Directorate, Western Australia Department of Health, Perth, WA.
Jardine A; Environmental Health Directorate, Western Australia Department of Health, Perth, WA.
Bloomfield LE; Communicable Disease Control Directorate, Western Australia Department of Health, Perth, WA.; The University of Notre Dame Australia, Fremantle, WA.
Effler PV; Communicable Disease Control Directorate, Western Australia Department of Health, Perth, WA.; Pokaż więcej
Źródło :: The Medical journal of Australia [Med J Aust] 2024 Apr 01; Vol. 220 (6), pp. 323-330. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji :: Journal Article
MeSH Terms :: SARS-CoV-2*
COVID-19*/epidemiology
Australasian People*
Adult ; Male ; Female ; Humans ; Post-Acute COVID-19 Syndrome ; Cross-Sectional Studies ; COVID-19 Vaccines ; Australia/epidemiology
SCR Organism :: SARS-CoV-2 variants
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccine.
Autorzy :: Montagud AC; Laboratorio de Inmunología, Plataforma Oncológica, Hospital QuironSalud Torrevieja. Torrevieja, Alicante, Spain.
Llenas-García J; Servicio de Medicina Interna, Hospital Vega Baja. Orihuela, Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante, Spain; Fundación para la Promoción de la Salud e Investigación Biomédica de Valencia, FISABIO, Valencia, Spain.
Moragues R; Departamento de Enfermería Comunitaria, Medicina Preventiva, Salud Pública e Historia de la Ciencia, Universidad de Alicante, Alicante, Spain.
Pérez-Bernabeu A; Servicio de Medicina Interna, Hospital Vega Baja. Orihuela, Alicante, Spain; Fundación para la Promoción de la Salud e Investigación Biomédica de Valencia, FISABIO, Valencia, Spain.
Alcocer Pertegal MJ; Dirección de Enfermería de Atención Primaria. Departamento de Salud de Orihuela, Orihuela, Alicante, Spain.
García Gómez FJ; Dirección de Enfermería Hospitalaria, Hospital Vega Baja. Orihuela, Alicante, Spain.
Gamayo Serna AM; Dirección de Enfermería Hospitalaria, Hospital Vega Baja. Orihuela, Alicante, Spain.
García Morante H; Servicio de Medicina Interna, Hospital Vega Baja. Orihuela, Alicante, Spain; Fundación para la Promoción de la Salud e Investigación Biomédica de Valencia, FISABIO, Valencia, Spain.
Caballero P; Departamento de Enfermería Comunitaria, Medicina Preventiva, Salud Pública e Historia de la Ciencia, Universidad de Alicante, Alicante, Spain.
Tuells J; Departamento de Enfermería Comunitaria, Medicina Preventiva, Salud Pública e Historia de la Ciencia, Universidad de Alicante, Alicante, Spain; Instituto de Salud e Investigación Biomédica de Alicante, (ISABIAL), Alicante, Spain. Electronic address: .; Pokaż więcej
Źródło :: Revista clinica espanola [Rev Clin Esp (Barc)] 2024 Apr; Vol. 224 (4), pp. 197-203. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Male ; Humans ; Female ; SARS-CoV-2 ; Prevalence ; Spain/epidemiology ; BNT162 Vaccine ; Health Personnel ; Antibodies, Neutralizing ; Serologic Tests ; COVID-19 Testing
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: The impact of preoperative coronavirus disease 19 infection on early postoperative mortality during the vaccination era: a nationwide retrospective cohort study.
Autorzy :: Ju JW; Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.
Kim T; Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.
Yoon SH; Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.
Kim WH; Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.; Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Korea.
Lee HJ; Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.; Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Korea.; Pokaż więcej
Źródło :: Korean journal of anesthesiology [Korean J Anesthesiol] 2024 Apr; Vol. 77 (2), pp. 185-194. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
Humans ; COVID-19 Testing ; COVID-19 Vaccines ; Retrospective Studies ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Emerging data in COVID-19 create urgent challengers for health providers: Updates on COVID-19 vaccine and Paxlovid.
Autorzy :: Mejia MC; Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr, Houston, 77098, TX, United States. Electronic address: .
Mitchell J; Charles E. Schmidt College of Medicine, Florida Atlantic University, United States.
Dumpa M; Charles E. Schmidt College of Medicine, Florida Atlantic University, United States.
Maki DG; Division of Infectious Disease and Hospital Epidemiologist, University of Wisconsin School of Medicine & Public Health, United States.
DiCorcia M; Charles E. Schmidt College of Medicine, Florida Atlantic University, United States.
Levine RS; Baylor College of Medicine, Charles E. Schmidt College of Medicine, Florida Atlantic University, United States.
Hennekens CH; Charles E. Schmidt College of Medicine, Florida Atlantic University, United States.; Pokaż więcej
Źródło :: Journal of the National Medical Association [J Natl Med Assoc] 2024 Apr; Vol. 116 (2 Pt 1), pp. 174-179. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza, Human*/prevention & control
Influenza Vaccines*
Ritonavir*
Nitriles*
Leucine*
Proline*
Lactams*
Child ; Adult ; Humans ; COVID-19 Vaccines/therapeutic use ; Drug Combinations
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Assessing Community Pharmacists' Perception on Readiness to Initiate Point-of-Care Testing for SARS-CoV-2 in New York State During the Pandemic.
Autorzy :: Ngwu RO; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA.; Middleport Family Health Center, Middleport, NY, USA.
Lindeau R; Primary care of Western New York, Buffalo, NY, USA.
Bielecki LM; Summit Park Pharmacy, Niagara Falls, NY, USA.
Daly CJ; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA.; Pokaż więcej
Źródło :: Journal of pharmacy practice [J Pharm Pract] 2024 Apr; Vol. 37 (2), pp. 324-334. Date of Electronic Publication: 2022 Oct 14.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/diagnosis
COVID-19*/epidemiology
Community Pharmacy Services*
Pharmacies*
Humans ; SARS-CoV-2 ; Pharmacists ; Pandemics ; COVID-19 Testing ; Cross-Sectional Studies ; New York/epidemiology ; Prospective Studies ; Point-of-Care Testing ; Perception ; Professional Role
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany.
Autorzy :: Schmachtenberg T; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany. .; Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. .
Königs G; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.
Roder S; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.; Department of Social Work, University of Applied Sciences and Arts Bielefeld, Interaktion 1, 33619, Bielefeld, Germany.
Müller F; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.; Department of Family Medicine, College of Human Medicine, Michigan State University, 15 Michigan St NE, Grand Rapids, 49503, East Lansing, MI, USA.
Müllenmeister C; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.
Schröder D; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.
El-Sayed I; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany.; Pokaż więcej
Źródło :: BMC public health [BMC Public Health] 2024 Mar 28; Vol. 24 (1), pp. 915. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/prevention & control
Vaccines*
Adult ; Humans ; Post-Acute COVID-19 Syndrome ; COVID-19 Vaccines ; Vaccination
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 16 16.

Tytuł :: Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.
Autorzy :: Colaneri M; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
Scaglione G; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Fassio F; Department of Public Health, Experimental and Forensic Medicine, Unit of Biostatistics and Clinical Epidemiology, University of Pavia, Pavia, Italy.
Galli L; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Lai A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Bergna A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Gabrieli A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Tarkowski M; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Ventura CD; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Colombo V; Department of Infectious Diseases, Unit I, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Cordier L; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Bernasconi D; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Corbellino M; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Dedivitiis G; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Borghetti S; Pharmacy Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Visigalli D; Pharmacy Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Sollima S; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Casalini G; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Rizzardini G; Department of Infectious Diseases, Unit I, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Gori A; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
Antinori S; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Riva A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Schiavini M; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy. .; Pokaż więcej
Źródło :: Virology journal [Virol J] 2024 Mar 20; Vol. 21 (1), pp. 68. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji :: Observational Study; Journal Article
MeSH Terms :: SARS-CoV-2*
COVID-19*
Lactams*
Leucine*
Nitriles*
Proline*
Humans ; Antibodies, Monoclonal/therapeutic use ; Ritonavir/therapeutic use ; COVID-19 Vaccines ; Retrospective Studies ; COVID-19 Drug Treatment ; Antiviral Agents/therapeutic use
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 17 17.

Tytuł :: Early Mortality After the First Dose of COVID-19 Vaccination: A Target Trial Emulation.
Autorzy :: McConeghy KW; Center of Innovation Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, USA.; Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, USA.
Hur K; VA Center for Medication Safety, Department of Veterans Affairs, Chicago, Illinois, USA.
Dahabreh IJ; CAUSALab, Harvard T. H. Chan School of Public Health, Boston, Massachusett, USA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Jiang R; VA Center for Medication Safety, Department of Veterans Affairs, Chicago, Illinois, USA.
Pandey L; VA Center for Medication Safety, Department of Veterans Affairs, Chicago, Illinois, USA.
Gellad WF; Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Centers for High Value Health Care, and Value-Based Pharmacy Initiatives, UPMC Health Plan, Pittsburgh, Pennsylvania, USA.
Glassman P; Pharmacy Benefits Management Services, Department of Veterans Affairs, Washington, DC, USA.; Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Good CB; VA Center for Medication Safety, Department of Veterans Affairs, Chicago, Illinois, USA.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Centers for High Value Health Care, and Value-Based Pharmacy Initiatives, UPMC Health Plan, Pittsburgh, Pennsylvania, USA.
Miller DR; VA Center for Medication Safety, Department of Veterans Affairs, Chicago, Illinois, USA.; Center for Population Health, Department of Biomedical and Nutritional Sciences, University of Massachusetts, Lowell, Massachusetts, USA.
Zullo AR; Center of Innovation Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, USA.; Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island, USA.
Gravenstein S; Center of Innovation Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, USA.; Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, USA.; Division of Geriatrics and Palliative Medicine, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Cunningham F; VA Center for Medication Safety, Department of Veterans Affairs, Chicago, Illinois, USA.; Pokaż więcej
Źródło :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Mar 20; Vol. 78 (3), pp. 625-632.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19*/prevention & control
Veterans*
Humans ; Adolescent ; Adult ; COVID-19 Vaccines/adverse effects ; COVID-19 Testing ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Influence of Preoperative COVID-19 Vaccination on Outcomes After Coronary Artery Bypass Grafting-A Propensity Score-Matched Analysis.
Autorzy :: Chang HW; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Ahn S; Biostatistics, Medical Research Collaborating Center Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Kim JS; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Han HJ; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Park YK; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Kim KM; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Kim SY; Department of Thoracic and Cardiovascular Surgery Chungnam National University Hospital Daejeon Republic of Korea.
Jung JC; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Lee JH; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Kim DJ; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Lim C; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.
Park KH; Department of Thoracic and Cardiovascular Surgery Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.; Pokaż więcej
Źródło :: Journal of the American Heart Association [J Am Heart Assoc] 2024 Mar 19; Vol. 13 (6), pp. e032426. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji :: Journal Article
MeSH Terms :: Coronary Artery Disease*/complications
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19*/complications
Aged ; Female ; Humans ; Middle Aged ; Coronary Artery Bypass ; COVID-19 Vaccines/administration & dosage ; Propensity Score ; Retrospective Studies ; Treatment Outcome ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: COVID-19 vaccination and the risk of autoimmune diseases: a Mendelian randomization study.
Autorzy :: Shan J; The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Hu X; Department of Pediatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Chen T; The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Wang Y; The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Huang B; The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xin Y; The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xu H; Department of Pediatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Pokaż więcej
Źródło :: Frontiers in public health [Front Public Health] 2024 Mar 14; Vol. 12, pp. 1322140. Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2024).
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
Autoimmune Diseases*/etiology
Autoimmune Diseases*/genetics
Colitis, Ulcerative*
Humans ; COVID-19 Vaccines ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis.
Autorzy :: Kitsios GD; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA .; Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Blacka S; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jacobs JJ; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Mirza T; Internal Medicine Residency Program, UPMC in Central Pa, Harrisburg, Pennsylvania, USA.
Naqvi A; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Gentry H; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Murray C; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Wang X; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Golubykh K; Internal Medicine Residency Program, UPMC in Central Pa, Harrisburg, Pennsylvania, USA.
Qurashi H; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Dodia A; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Risbano M; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Benigno M; Pfizer Inc, New York, New York, USA.
Emir B; Pfizer Inc, New York, New York, USA.
Weinstein E; Pfizer Inc, New York, New York, USA.
Bramson C; Pfizer Inc, New York, New York, USA.
Jiang L; Pfizer Inc, New York, New York, USA.
Dai F; Pfizer Inc, New York, New York, USA.
Szigethy E; Department of Psychiatry and Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Mellors JW; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Methe B; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Sciurba FC; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Emphysema Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Nouraie SM; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Morris A; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Pokaż więcej
Źródło :: BMJ open [BMJ Open] 2024 Mar 14; Vol. 14 (3), pp. e077869. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji :: Observational Study; Journal Article
MeSH Terms :: Post-Acute COVID-19 Syndrome*
COVID-19*/epidemiology
Adult ; Humans ; Prospective Studies ; Self Report ; COVID-19 Testing ; Latent Class Analysis ; RNA, Viral ; SARS-CoV-2 ; Disease Progression ; Dyspnea
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaBiblioteka UWSB Merito Chorzów

Wyszukujesz frazę ""COVID-19"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Dostawca treści

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Hasło geograficzne

Kategoria

Rok publikacji